Skip to main content
PMC home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
letter
. 1977 Aug;69(8):581–584.

Aspirin for Reducing Cancer Metastases?

Ulrich K Henschke, G Jeff Luande, Johnson D Choppala
PMCID: PMC2609613  PMID: 904011

Abstract

Distant metastases are the principal cause of death from cancer. Many animal experiments in the last 25 years have shown consistently that distant metastases can be significantly reduced by anticoagulants and fibrinolytic agents. Since aspirin inhibits platelet function and increases fibrinolytic activity in humans, it may be effective in preventing metastases in cancer patients. It is suggested that aspirin be offered as an option to cancer patients who are at risk for distant metastases.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agostino D. Are the showers of cancer cells in the blood responsible for an increase in metastases? Tumori. 1968 Nov-Dec;54(6):427–440. doi: 10.1177/030089166805400602. [DOI] [PubMed] [Google Scholar]
  2. Agostino D., Cliffton E. E. Circulating Walker 256 carcinoma cells in the spleen. Arch Surg. 1967 Mar;94(3):313–315. doi: 10.1001/archsurg.1967.01330090007002. [DOI] [PubMed] [Google Scholar]
  3. Agostino D., Cliffton E. E. Organ localization and the effect of trauma on the fate of circulating cancer cells. Cancer Res. 1965 Nov;25(10):1728–1732. [PubMed] [Google Scholar]
  4. BEAUMONT J. L., CAEN J., BERNARD J. Influence de l'acide acétyl salicylique dans les maladies hémorragiques. Sang. 1956;27(3):243–248. [PubMed] [Google Scholar]
  5. BEAUMONT J. L., WILLIE A. Influence sur l'hémostase, de l'hypertension artérielle, des antivitamines K, de l'héparine et de l'acide acétyl salicylique. Sang. 1955;26(9):880–891. [PubMed] [Google Scholar]
  6. BLATRIX C. [Prolonged bleeding time under the influence of certain drugs]. Nouv Rev Fr Hematol. 1963 May-Jun;3:346–350. [PubMed] [Google Scholar]
  7. CLIFFTON E. E., AGOSTINO D. Cancer cells in the blood in simulated colon cancer, resectable and unresectable: effect of fibrinolysin and heparin on growth potential. Surgery. 1961 Aug;50:395–401. [PubMed] [Google Scholar]
  8. CLIFFTON E. E., AGOSTINO D. EFFECT OF INHIBITORS OF FIBRINOLYTIC ENZYMES ON DEVELOPMENT OF PULMONARY METASTASES. J Natl Cancer Inst. 1964 Nov;33:753–763. doi: 10.1093/jnci/33.5.753. [DOI] [PubMed] [Google Scholar]
  9. CLIFFTON E. E., AGOSTINO D. Factors affecting the development of metastatic cancer. Effect of alterations in clottin mechanism. Cancer. 1962 Mar-Apr;15:276–283. doi: 10.1002/1097-0142(196203/04)15:2<276::aid-cncr2820150211>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  10. CLIFFTON E. E., AGOSTINO D. THE EFFECTS OF FIBRIN FORMATION AND ALTERATIONS IN THE CLOTTING MECHANISM ON THE DEVELOPMENT OF METASTASES. Vasc Dis. 1965 Jan;2:43–52. [PubMed] [Google Scholar]
  11. CRAVEN L. L. Acetylsalicylic acid, possible preventive of coronary thrombosis. Ann West Med Surg. 1950 Feb;4(2):95–95. [PubMed] [Google Scholar]
  12. CRAVEN L. L. Experiences with aspirin (Acetylsalicylic acid) in the nonspecific prophylaxis of coronary thrombosis. Miss Valley Med J. 1953 Jan;75(1):38–44. [PubMed] [Google Scholar]
  13. CRAVEN L. L. Prevention of coronary and cerebral thrombosis. Miss Valley Med J. 1956 Sep;78(5):213–215. [PubMed] [Google Scholar]
  14. Cliffton E. E. Effect of fibrinolysin on spread of cancer. Fed Proc. 1966 Jan-Feb;25(1):89–93. [PubMed] [Google Scholar]
  15. Elwood P. C., Cochrane A. L., Burr M. L., Sweetnam P. M., Williams G., Welsby E., Hughes S. J., Renton R. A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J. 1974 Mar 9;1(5905):436–440. doi: 10.1136/bmj.1.5905.436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. GASIC G., GASIC T. Removal of sialic acid from the cell coat in tumor cells and vascular endothelium, and its effects on metastasis. Proc Natl Acad Sci U S A. 1962 Jul 15;48:1172–1177. doi: 10.1073/pnas.48.7.1172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. GAST L. F. INFLUENCE OF ASPIRIN ON HAEMOSTATIC PARAMETERS. Ann Rheum Dis. 1964 Nov;23:500–504. doi: 10.1136/ard.23.6.500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gasic G. J., Gasic T. B., Galanti N., Johnson T., Murphy S. Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease. Int J Cancer. 1973 May;11(3):704–718. doi: 10.1002/ijc.2910110322. [DOI] [PubMed] [Google Scholar]
  19. Gasic G. J., Gasic T. B., Murphy S. Anti-metastatic effect of aspirin. Lancet. 1972 Oct 28;2(7783):932–933. doi: 10.1016/s0140-6736(72)92581-0. [DOI] [PubMed] [Google Scholar]
  20. Gasic G. J., Gasic T. B., Stewart C. C. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A. 1968 Sep;61(1):46–52. doi: 10.1073/pnas.61.1.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. HOFMANN H. Experimentelle Untersuchungen zur Frage der Blutungszeitveränderung durch Salizylate. Med Monatsschr. 1956 Feb;10(2):84–87. [PubMed] [Google Scholar]
  22. Hammond E. C., Garfinkel L. Aspirin and coronary heart disease: findings of a prospective study. Br Med J. 1975 May 3;2(5965):269–271. doi: 10.1136/bmj.2.5965.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Heikinheimo R., Järvinen K. Acetylsalicylic acid and arteriosclerotic-thromboembolic diseases in the aged. J Am Geriatr Soc. 1971 May;19(5):403–405. doi: 10.1111/j.1532-5415.1971.tb03234.x. [DOI] [PubMed] [Google Scholar]
  24. Hilgard P., Thornes R. D. Anticoagulants in the treatment of cancer. Eur J Cancer. 1976 Oct;12(10):755–762. doi: 10.1016/0014-2964(76)90088-8. [DOI] [PubMed] [Google Scholar]
  25. JOHNSON J. H., WOODS J. R. AN IN VITRO STUDY OF FIBRINOLYTIC AGENTS ON V2 CARCINOMA CELLS AND INTRAVASCULAR THROMBI IN RABBITS. Bull Johns Hopkins Hosp. 1963 Dec;113:335–346. [PubMed] [Google Scholar]
  26. Jick H., Miettinen O. S. Regular aspirin use and myocardial infarction. Br Med J. 1976 May 1;1(6017):1057–1057. doi: 10.1136/bmj.1.6017.1057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ketcham A. S., Wexler H., Minton J. P. Experimental study of metastases. JAMA. 1966 Oct 10;198(2):157–164. [PubMed] [Google Scholar]
  28. Kolenich J. J., Mansour E. G., Flynn A. Haematological effects of aspirin. Lancet. 1972 Sep 30;2(7779):714–714. doi: 10.1016/s0140-6736(72)92124-1. [DOI] [PubMed] [Google Scholar]
  29. LACOUR F., OBERLING C., GUERIN M. Influence de l'ethyl-dicoumarol sur l'évolution des métastases de l'epithélioma T8 chez le rat; note préliminaire. Bull Assoc Fr Etud Cancer. 1955;42(5):531–536. [PubMed] [Google Scholar]
  30. Moroz L. A. Increased blood fibrinolytic activity after aspirin ingestion. N Engl J Med. 1977 Mar 10;296(10):525–529. doi: 10.1056/NEJM197703102961001. [DOI] [PubMed] [Google Scholar]
  31. O'Brien J. R. Effects of salicylates on human platelets. Lancet. 1968 Apr 13;1(7546):779–783. doi: 10.1016/s0140-6736(68)92228-9. [DOI] [PubMed] [Google Scholar]
  32. Powles T. J., Clark S. A., Easty D. M., Easty G. C., Neville A. M. The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer. Br J Cancer. 1973 Oct;28(4):316–321. doi: 10.1038/bjc.1973.154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Quick A. J. Salicylates and bleeding: the aspirin tolerance test. Am J Med Sci. 1966 Sep;252(3):265–269. doi: 10.1097/00000441-196609000-00003. [DOI] [PubMed] [Google Scholar]
  34. Ryan J. J., Ketcham A. S., Wexler H. Reduced incidence of spontaneous metastases with long-term Coumadin therapy. Ann Surg. 1968 Jul;168(1):163–168. doi: 10.1097/00000658-196807000-00021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ryan J. J., Ketcham A. S., Wexler H. Warfarin therapy as an adjunct to the surgical treatment of malignant tumors in mice. Cancer Res. 1969 Dec;29(12):2191–2194. [PubMed] [Google Scholar]
  36. Ryan J. J., Ketcham A. S., Wexler H. Warfarin treatment of mice bearing autochthonous tumors: effect on spontaneous metastases. Science. 1968 Dec 27;162(3861):1493–1494. doi: 10.1126/science.162.3861.1493. [DOI] [PubMed] [Google Scholar]
  37. Ryan J. J., Orme S. K., Wexler H., Ketcham A. S. Successful long-term coumadin anticoagulation of mice with prothrombin time monitoring. J Surg Oncol. 1969;1(2):115–121. doi: 10.1002/jso.2930010204. [DOI] [PubMed] [Google Scholar]
  38. Salzman E. W., Harris W. H., DeSanctis R. W. Reduction in venous thromboembolism by agents affecting platelet function. N Engl J Med. 1971 Jun 10;284(23):1287–1292. doi: 10.1056/NEJM197106102842303. [DOI] [PubMed] [Google Scholar]
  39. TERRANOVA T., CHIOSSONE F. Il fattore coagulazione nell'attecchimento delle cellule neoplastiche immesse in circolo. Boll Soc Ital Biol Sper. 1952 Jun;28(6):1224–1225. [PubMed] [Google Scholar]
  40. WOOD J. S., Jr, HOLYOKE E. D., SOMMERS S. C., WARREN S. Influence of pituitary growth hormone on growth and metastasis formation of a transplantable mouse sarcoma. Bull Johns Hopkins Hosp. 1955 Mar;96(3):93–100. [PubMed] [Google Scholar]
  41. WOODS J. R. EXPERIMENTAL STUDIES OF THE INTRAVASCULAR DISSEMINATION OF ASCITIC V2 CARCINOMA CELLS IN THE RABBIT, WITH SPECIAL REFERENCE TO FIBRINOGEN AND FIBRINOLYTIC AGENTS. Bull Schweiz Akad Med Wiss. 1964 May;20:92–121. [PubMed] [Google Scholar]
  42. Weiss H. J., Aledort L. M. Impaired platelet-connective-tissue reaction in man after aspirin ingestion. Lancet. 1967 Sep 2;2(7514):495–497. doi: 10.1016/s0140-6736(67)91658-3. [DOI] [PubMed] [Google Scholar]
  43. Wood S., Jr, Hilgard P. Aspirin and tumour metastasis. Lancet. 1972 Dec 30;2(7792):1416–1417. doi: 10.1016/s0140-6736(72)92982-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES